Standard BioTools Inc.
LAB
$1.50
$0.074.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.16% | 7.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.16% | 7.62% | |||
| Cost of Revenue | -40.34% | 18.22% | |||
| Gross Profit | 94.07% | -17.84% | |||
| SG&A Expenses | -5.37% | -5.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.37% | 2.30% | |||
| Operating Income | 0.98% | 2.13% | |||
| Income Before Tax | -79.96% | 22.17% | |||
| Income Tax Expenses | -99.67% | -411.76% | |||
| Earnings from Continuing Operations | -79.28% | 24.38% | |||
| Earnings from Discontinued Operations | 80.98% | -492.79% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.67% | -28.53% | |||
| EBIT | 0.98% | 2.13% | |||
| EBITDA | -10.99% | 1.69% | |||
| EPS Basic | -3.19% | -27.76% | |||
| Normalized Basic EPS | -43.45% | 33.08% | |||
| EPS Diluted | -3.19% | -27.76% | |||
| Normalized Diluted EPS | -43.45% | 33.08% | |||
| Average Basic Shares Outstanding | 0.56% | 0.60% | |||
| Average Diluted Shares Outstanding | 0.56% | 0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||